Abu-Hejleh T, Chrischilles EA, Halfdanarson TR, Simon C, Pendergast JF, Jiang D, Smith CJ, Porter AT, Carter KD, Wallace RB; Cancer Care Outcomes Research and Surveillance Consortium (CanCORS).
The Effect of Receiving Treatment Within a Clinical Trial Setting on Survival and Quality of Care Perception in Advanced Stage Non-Small Cell Lung Cancer.
Am J Clin Oncol. 2016 Apr;39(2):126-31.

Ammann EM, Haskins CB, Fillman KM, Ritter RL, Gu X, Winiecki SK, Carnahan RM, Torner JC, Fireman BH, Jones MP, Chrischilles EA.
Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs.
Am J Hematol. 2016 Mar 11.

Ammann EM, Jones MP, Link BK, Carnahan RM, Winiecki SK, Torner JC, McDowell BD, Fireman BH, Chrischilles EA.
Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy. Blood.
2016 Jan 14;127(2):200-7.

Anderegg MD, Gums TH, Uribe L, Coffey CS, James PA, Carter BL.
Physician-Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap.
Hypertension. 2016 Nov;68(5):1314-1320.

Bali V, Chatterjee S, Johnson ML, Chen H, Carnahan RM, Aparasu RR.
Risk of Cognitive Decline Associated With Paroxetine Use in Elderly Nursing Home Patients With Depression.
Am J Alzheimers Dis Other Demen. 2016 Dec;31(8):678-686.

Carter BL.
Evolution of Clinical Pharmacy in the USA and Future Directions for Patient Care.
Drugs Aging. 2016 Mar;33(3):169-77.

Carter BL.
Primary Care Physician-Pharmacist Collaborative Care Model: Strategies for Implementation.
Pharmacotherapy. 2016 Mar 2.

Carter BL, Ardery G.
Avoiding Pitfalls With Implementation of Randomized Controlled Multicenter Trials: Strategies to Achieve Milestones.
J Am Heart Assoc. 2016 Dec 19;5(12). Review.

Chapman CG, Brooks JM.
Treatment Effect Estimation Using Nonlinear Two-Stage Instrumental Variable Estimators: Another Cautionary Note.
Health Serv Res. 2016 Dec;51(6):2375-2394.

Charlton ME, Hrabe JE, Wright KB, Schlichting JA, McDowell BD, Halfdanarson TR, Lin C, Stitzenberg KB, Cromwell JW.
Hospital Characteristics Associated with Stage II/III Rectal Cancer Guideline Concordant Care: Analysis of Surveillance, Epidemiology and End Results-Medicare Data.
J Gastrointest Surg. 2016 May;20(5):1002-11.

Charlton ME, Matthews KA, Gaglioti A, Bay C, McDowell BD, Ward MM, Levy BT.
Is Travel Time to Colonoscopy Associated With Late-Stage Colorectal Cancer Among Medicare Beneficiaries in Iowa?
J Rural Health. 2016 Sep;32(4):363-373.

Chatterjee S, Bali V, Carnahan RM, Johnson ML, Chen H, Aparasu RR.
Anticholinergic Medication Use and Risk of Dementia Among Elderly Nursing Home Residents with Depression.
Am J Geriatr Psychiatry. 2016 Feb 17.

Chatterjee S, Carnahan RM, Chen H, Holmes HM, Johnson ML, Aparasu RR.
Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study.
J Am Geriatr Soc. 2016 Feb;64(2):394-400.

Chrischilles EA, Schneider KM, Schroeder MC, Letuchy E, Wallace RB, Robinson JG, Brooks JM.
Association Between Preadmission Functional Status and Use and Effectiveness of Secondary Prevention Medications in Elderly Survivors of Acute Myocardial Infarction.
J Am Geriatr Soc. 2016 Mar;64(3):526-35.

Dandapat S, Robinson JG.
Guidelines for Management of Hyperlipidemia: Implications for Treatment of Patients with Stroke Secondary to Atherosclerotic Disease.
Curr Neurol Neurosci Rep. 2016 Mar;16(3):24.

Doucette WR, Rippe JJ, Gaither CA, Kreling DH, Mott DA, Schommer JC.
Influences on the frequency and type of community pharmacy services.
J Am Pharm Assoc (2003). 2017 Jan – Feb;57(1):72-76.e1.

Doucette WR, Vinel S, Pennathur P.
Initial development of the Systems Approach to Home Medication Management (SAHMM) model.
Res Social Adm Pharm. 2016 Jan 7.

Farris KB, Salgado TM, Aneese N, Marshall VD, Pendergast JF, Frank J, Chrischilles EA, Doucette WR.
Effect of Clinical and Attitudinal Characteristics on Obtaining Comprehensive Medication Reviews.
J Manag Care Spec Pharm. 2016 Apr;22(4):388-95.

Gagne JJ, Han X, Hennessy S, Leonard CE, Chrischilles EA, Carnahan RM, Wang SV, Fuller C, Iyer A, Katcoff H, Woodworth TS, Archdeacon P, Meyer TE, Schneeweiss S, Toh S.
Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association.
Clin Pharmacol Ther. 2016 Nov;100(5):558-564.

Goedken AM, Lund BC, Cook EA, Schroeder MC, Brooks JM.
Application of a framework for determining number of drugs.
BMC Res Notes. 2016 May 13;9:272.

Gruca TS, Pyo TH, Nelson GC.
Improving Rural Access to Orthopaedic Care Through Visiting Consultant Clinics.
J Bone Joint Surg Am. 2016 May 4;98(9):768-74.

Gruca TS, Pyo TH, Nelson GC.
Providing Cardiology Care in Rural Areas Through Visiting Consultant Clinics.
J Am Heart Assoc. 2016 Jun 30;5(7).

Hughley BB, Sperry SM, Thomsen TA, Charlton ME, Pagedar NA.
Survival outcomes in elderly patients with untreated upper aerodigestive tract cancer.
Head Neck. 2017 Feb;39(2):215-218.

Isetts BJ, Buffington DE, Carter BL, Smith M, Polgreen LA, James PA.
Evaluation of Pharmacists’ Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
Pharmacotherapy. 2016 Feb 19.

Jorgensen SM, Carnahan RM, Weckmann MT.
Validity of the Delirium Observation Screening Scale in Identifying Delirium in Home Hospice Patients.
Am J Hosp Palliat Care. 2016 Jul 13.

Karnell LH, Sperry SM, Anderson CM, Pagedar NA.
Influence of body composition on survival in patients with head and neck cancer.
Head Neck. 2016 Apr;38 Suppl 1:E261-7.

Link BK.
Will a Better Understanding of the Problem With Transformed Follicular Lymphoma Lead to Better Outcomes?
J Clin Oncol. 2016 Aug 1;34(22):2566-7.

Lund BC, Charlton ME, West AN.
Pharmacy use by dual-eligible non-elderly veterans with private healthcare insurance.
BMC Health Serv Res. 2016 Sep 23;16(1):515.

Raman R, Mott SL, Schroeder MC, Phadke S, El Masri J, Thomas A.
Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.
Clin Breast Cancer. 2016 Dec;16(6):480-486.

Riedle BN, Polgreen LA, Cavanaugh JE, Schroeder MC, Polgreen PM.
Phantom Prescribing: Examining the Frequency of Antimicrobial Prescriptions Without a Patient Visit.
Infect Control Hosp Epidemiol. 2016 Dec 13:1-8.

Robinson JG.
Lower might be better – It matters how you get there, and in whom.
Eur Heart J. 2016 May 1;37(17):1380-3.

Robinson JG.
Nonstatins and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Role in Non-Familial Hypercholesterolemia.
Prog Cardiovasc Dis. 2016 Sep – Oct;59(2):165-171.

Robinson JG.
The future of lipid guidelines.
Curr Opin Lipidol. 2016 Dec;27(6):585-591.

Robinson JG, Huijgen R, Ray K, Persons J, Kastelein JJ, Pencina MJ.
Determining When to Add Nonstatin Therapy: A Quantitative Approach.
J Am Coll Cardiol. 2016 Dec 6;68(22):2412-2421.

Robinson JG, Ray K.
Counterpoint: Low-Density Lipoprotein Cholesterol Targets Are Not Needed in Lipid Treatment Guidelines.
Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):586-90.

Robinson JG, Ray K.
Moving Toward the Next Paradigm for Cardiovascular Prevention.
Circulation. 2016 Apr 19;133(16):1533-6.

Schroeder MC, Chapman CG, Nattinger MC, Halfdanarson TR, Abu-Hejleh T, Tien YY, Brooks JM.
Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational study.
BMC Health Serv Res. 2016 Jul 18;16:274.

Schroeder MC, Tien YY, Wright K, Halfdanarson TR, Abu-Hejleh T, Brooks JM.
Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer.
Lung Cancer. 2016 May;95:28-34.

Schweizer ML, Braun BI, Milstone AM.
Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship-Quasi-Experimental Designs.
Infect Control Hosp Epidemiol. 2016 Oct;37(10):1135-40.

Smith SM, Carris NW, Dietrich E, Gums JG, Uribe L, Coffey CS, Gums TH, Carter BL.
Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.
J Am Soc Hypertens. 2016 Apr;10(4):307-17.

Steinberg RL, Thomas LJ, Nepple KG.
Intravesical and alternative bladder-preservation therapies in the management of non-muscle-invasive bladder cancer unresponsive to bacillus Calmette-Guérin.
Urol Oncol. 2016 Jun;34(6):279-89. Review.

Thomas A, Khan SA, Chrischilles EA, Schroeder MC.
Initial Surgery and Survival in Stage IV Breast Cancer in the United States, 1988-2011.
JAMA Surg. 2016 May 1;151(5):424-31.

Thomas A, Weigel RJ, Lynch CF, Spanheimer PM, Breitbach EK, Schroeder MC.
Incidence, characteristics, and management of recently diagnosed, microscopically invasive breast cancer by receptor status: Iowa SEER 2000 to 2013.
Am J Surg. 2016 Sep 2.

Tyler Ellis C, Charlton ME, Stitzenberg KB.
Patient-Reported Roles, Preferences, and Expectations Regarding Treatment of Stage I Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium.
Dis Colon Rectum. 2016 Oct;59(10):907-15.

Urick BY, Kaskie BP, Carnahan RM.
Improving antipsychotic prescribing practices in nursing facilities: The role of surveyor methods and surveying agencies in upholding the Nursing Home Reform Act.
Res Social Adm Pharm. 2016 Jan-Feb;12(1):91-103.

Van Liew JR, Brock RL, Christensen AJ, Karnell LH, Pagedar NA, Funk GF.
Weight loss after head and neck cancer: A dynamic relationship with depressive symptoms.
Head Neck. 2017 Feb;39(2):370-379.

Wright AA, Keating NL, Ayanian JZ, Chrischilles EA, Kahn KL, Ritchie CS, Weeks JC, Earle CC, Landrum MB.
Family Perspectives on Aggressive Cancer Care Near the End of Life.
JAMA. 2016 Jan 19;315(3):284-92.